Pierre Fabre Partners with XtalPi to Advance AI-Driven Drug Discovery
Under the agreement, XtalPi will deploy its integrated AI capabilities and robotics platform to design and deliver novel small-molecule therapeutics against undisclosed targets.
Raymond Zheng | 09/11/2026 | By Abha Rustagi
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy